[1]. Naghavi M. The global burden of cancer. JAMA Oncol 2015; 1: 505–27.
[2] Liu Y, Zhang Q, Ren C, Ding Y, Jin G, et al. A germline variant N375S in MET and gastric cancer susceptibility in a Chinese population. J Biomed Res 2012; 26: 315–318.
[3] Wang W, Li Y-F., Sun X-W, et al. Prognosis of 980 patients with gastric cancer after surgical resection [J]. Chinese Journal of Cancer. 2010; 29(11): 923–930.
[4] Deng K, Yang L, Hu B, Wu H, Zhu H, Tang C. The prognostic significance of pretreatment serum cea levels in gastric cancer: a meta-analysis including 14,651 patients. PLoS ONE. 2015; 4: e124151.
[5]. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357:539–45.
[6]. Coussens LM, Werb Z. Inflammation and cancer. Nature, 2002;420:860–7.
[7]. Proctor MJ, Talwar D, Balmar SM, et al. The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study. Br J Cancer 2010; 103:870–6.
[8] Huang XZ, Yang YC, Chen Y, et al. Preoperative Anemia or Low Hemoglobin Predicts Poor Prognosis in Gastric Cancer Patients: A Meta-Analysis. Dis Markers. 2019;2019:7606128. Published 2019 Jan 2.
[10] Carruthers R, Tho LM, Brown J, Kakumanu S, McCartney E and McDonald AC: Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer. Colorectal Dis 2012; 14: e701-707.
[12]Sun X, Liu X, Liu J,et al. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer. Chin J Cancer 2016;35:57.
[13]. Ishizuka M, Oyama Y, Abe A, Kubota K. Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients undergoing surgery for gastric cancer. J Surg Oncol. 2014;110(8):935–41.
[14] B. L. Wang, L. Tian, X. H. Gao et al., “Dynamic change of the systemic immune inflammation index predicts the prognosis of patients with hepatocellular carcinoma after curative resection, ”Clinical Chemistry and Laboratory Medicine, vol. 54, no. 12, pp. 1963–1969, 2016.
[15] Y. Geng, Y. Shao, D. Zhu et al., “Systemic immune inflammation index predicts prognosis of patients with esophageal squamous cell carcinoma: a propensity score-matched analysis,” Scientific Reports, vol. 6, no. 1, article 39482, 2016. [14] Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32–5.
[16] Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32–5.
[17] Zivanovic O, Jacks LM, Iasonos A et al. A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma. Cancer 2012; 118: 660–9.
[18] Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J. Clin. Oncol. Off. J. Am. Soc. Clin.Oncol. 2008; 26: 1364–70.
[19] Roxburgh CS,Salmond JM,Horgan PG,et al.The relationship between the local and systemic inflammatory responses and survival in patients undergoing curative surgery for colon and rectal cancers[J].J Gastrointest Surg,2009,13:2011-2018.
[20] S.I. Grivennikov, F.R. Greten, M. Karin, Immunity, inflammation, and cancer, Cell140 (2010) 883–899.
[21] Smyth MJ, Dunn GP, Schreiber RD. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity [J]. Adv Immunol, 2006,90:1–50.
[22] D. Schumacher, B. Strilic, K. K. Sivaraj, N. Wettschureck, and S. Offermanns, “Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via
p2y2 receptor,” Cancer Cell, vol. 24, no. 1, pp. 130–137, 2013.
[23] Shu-Bei Wang, Wei-Xiang Qi, Jia-Yi Chen, et al. Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy. Radiation Oncology , 2019, 14(1): 128.